COSMETIC PATCHES CONTAINING SOY ISOFLAVONES

Similar documents
STANDARD OPERATING PROTOCOL (SOP)

Analysis of Isoflavones with the PerkinElmer Flexar FX-15 UHPLC System Equipped with a PDA Detector

STANDARD OPERATING PROTOCOL (SOP)

Topical Preparations

Evaluation of the Percutaneous Absorption of Tramadol, In Lipoderm, Into Inner Ear Feline Skin, In Vitro, Using the Franz Skin Finite Dose Model

Application Note Soy for Isoflavones by HPLC. Botanical Name: Glycine max L. Common Names: Parts of Plant Used: Beans.

Comparative ex vivo and in vitro Permeation Kinetics of Tocopherol in Liquid Formulations

Formulation Factors. Other Considerations. Transdermal Drug Delivery

Transdermal Delivery of Newer Atypical Antipsychotics ABSTRACT

ISOFLAVONE CHARACTERIZATION FROM LEGUMES OTHER THAN SOYBEANS. Koh L.W. 1 and Perera C.O. 2

Rapid and sensitive UHPLC screening of additives in carbonated beverages with a robust organic acid column

TENOFOVIR TABLETS: Final text for addition to The International Pharmacopoeia (June 2010)

RITONAVIRI COMPRESSI RITONAVIR TABLETS. Final text for addition to The International Pharmacopoeia (July 2012)

Rapid and sensitive UHPLC screening for water soluble vitamins in sports beverages

Extended Application Note

Rapid Gradient and Elevated Temperature UHPLC of Flavonoids in Citrus Fruit

[ application note note ] ]

Extraction of Multiple Mycotoxins From Nuts Using ISOLUTE Myco prior to LC-MS/MS Analysis

Application Note. Agilent Application Solution Analysis of fat-soluble vitamins from food matrix for nutrition labeling. Abstract.

Analysis of Commercially Available Products Containing Stevia

Validation of Changes to the USP Assay Method for Ibuprofen Tablets

CHAPTER INTRODUCTION OF DOSAGE FORM AND LITERATURE REVIEW

Residue Monograph prepared by the meeting of the Joint FAO/WHO Expert Committee on Food Additives (JECFA), 82 nd meeting 2016.

DRAFT MONOGRAPH FOR THE INTERNATIONAL PHARMACOPOEIA EFAVIRENZ, EMTRICITABINE AND TENOFOVIR TABLETS

4. VISIBLE SPECTROPHOTOMETRIC DETERMINATION OF. Fulvestrant is primarily used in the treatment of hormone receptor

Application Note. Agilent Application Solution Analysis of ascorbic acid, citric acid and benzoic acid in orange juice. Author. Abstract.

4. Monitoring of dissolution induced changes in film coat

Determination of Isoflavones in Soybean by LC/MS/MS

HUMAN LIVER SLICE EXPERIMENT 1 Effects of Propylene Glycol on Ethylene Glycol Metabolism

CYCLOSERINI CAPSULAE - CYCLOSERINE CAPSULES (AUGUST 2015)

TSKgel Size Exclusion Chromatography Columns

Analytical Method for 2, 4, 5-T (Targeted to Agricultural, Animal and Fishery Products)

SUMMARY, CONCLUSION & RECOMMENDATIONS

Chromatography on Immobilized Artificial Membrane

Title Revision n date

CHAPTER-2. Table of Contents. S.No. Name of the Sub-Title Page No. 2.1 Literature survey for simultaneous estimation of selected drugs by RP-HPLC

Sucrose Esters of Fatty Acids

Determination of β2-agonists in Pork Using Agilent SampliQ SCX Solid-Phase Extraction Cartridges and Liquid Chromatography-Tandem Mass Spectrometry

Extraction of Multiple Mycotoxins From Grain Using ISOLUTE Myco prior to LC-MS/MS Analysis

Development and Validation for Simultaneous Estimation of Sitagliptin and Metformin in Pharmaceutical Dosage Form using RP-HPLC Method

RP-HPLC Analysis of Temozolomide in Pharmaceutical Dosage Forms

EMTRICITABINE AND TENOFOVIR TABLETS

Extraction of Aflatoxin M1 From Infant Formula Using ISOLUTE Myco SPE Columns prior to LC-MS/MS Analysis

Enhanced delivery methods for greater efficacy

J Pharm Sci Bioscientific Res (4): ISSN NO

Preparation and characterization of Aloe vera extract

CLINDAMYCIN PALMITATE

Impurity Profiling of Carbamazepine by HPLC/UV

Tenofovir disoproxil fumarate (Tenofoviri disoproxili fumaras)

[ APPLICATION NOTE ] Profiling Mono and Disaccharides in Milk and Infant Formula Using the ACQUITY Arc System and ACQUITY QDa Detector

School of Pharmacy Faculty of Medicine The Chinese University of Hong Kong. Transdermal Drug Delivery System

CHAPTER 8 HIGH PERFORMANCE LIQUID CHROMATOGRAPHY (HPLC) ANALYSIS OF PHYTOCHEMICAL CONSTITUENTS OF M. ROXBURGHIANUS AND P. FRATERNUS PLANT EXTRACTS

LC-MS/MS Method for the Determination of Tenofovir from Plasma

Application Note. Authors. Abstract. Food

ZIDOVUDINE, LAMIVUDINE AND ABACAVIR TABLETS Draft proposal for The International Pharmacopoeia (September 2006)

New RP - HPLC Method for the Determination of Valproic acid in Human Plasma

SeQuant ZIC -HILIC For all who expect more...

RP-HPLC Method Development and Validation of Abacavir Sulphate in Bulk and Tablet Dosage Form

SeQuant ZIC -HILIC For all who expect more...

Analysis of anti-epileptic drugs in human serum using an Agilent Ultivo LC/TQ

ISSN: ; CODEN ECJHAO E-Journal of Chemistry 2011, 8(3),

Determination of Tetracyclines in Chicken by Solid-Phase Extraction and High-Performance Liquid Chromatography

CYCLOSERINE Proposal for revision of The International Pharmacopoeia (August 2012)

This PDF is available for free download

DETERMINATION OF SOME ISOFLAVONOIDS AND FLAVONOIDS FROM LIMONIA ACIDISSIMA L. BY HPLC-UV

Matrix-induced Signal Enhancement of Propamocarb in LC-MS/MS

PROPOSAL FOR REVISION OF MONOGRAPH PUBLISHED IN The International Pharmacopoeia: REVISION OF ph test ABACAVIR ORAL SOLUTION (JULY 2012)

Summary Chapter 8 CHAPTER 8. Summary. Page 173

Systematic Evaluation of Solid Phase Extraction (SPE) Chemistries for the Determination of Acidic, Neutral, and Basic Drugs

Chapter - V RESULTS AND DISCUSSION

Rebaudioside a From Multiple Gene Donors Expressed in Yarrowia Lipolytica

Hyderabad, India. Department of Pharmaceutical Chemistry, Glocal University, Saharanpur, India.

Amphetamines, Phentermine, and Designer Stimulant Quantitation Using an Agilent 6430 LC/MS/MS

Comparison of a UPLC Method across Multiple UHPLC Systems

The Function of Emollients in Skin Care

F. Al-Rimawi* Faculty of Science and Technology, Al-Quds University, P.O. Box 20002, East Jerusalem. Abstract

Development and validation of stability indicating RP-LC method for estimation of calcium dobesilate in pharmaceutical formulations

IJPAR Vol.3 Issue 4 Oct-Dec-2014 Journal Home page:

PAPRIKA EXTRACT SYNONYMS DEFINITION DESCRIPTION FUNCTIONAL USES CHARACTERISTICS

SIMPLE AND VALIDATED RP-HPLC METHOD FOR THE ESTIMATION OF CARBOPLATIN IN BULK AND FORMULATION DOSAGE FORM. Subhashini.Edla* B.

The Ephedra Story: An Automated SPE Procedure and Analysis for the Determination of Ephedra and Ephedra-like Compounds in Dietary Supplements

C30 ISOMERS HAVE MET THEIR MATCH

Dhull Rohit, Kumar Sanjay, Jalwal Pawan Department of Chemistry, OPJS Churu, Rajasthan, India

AMIODARONE and DESETHYLAMIODARONE IN PLASMA BY UV FAST CODE Z33610

Analysis of HMF by HPLC

Application Note. Author. Abstract. Introduction. Food Safety

Determination of glycerol derivatives by High-performance liquid chromatography

VITAMIN B1 & B6 VITAMIN B1&B6 COMBI-DETERMINATION IN EDTA- OF HEPARINE WHOLE BLOOD. HPLC & UPLC Method

Comprehensive Study of SLE as a Sample. Preparation Tool for Bioanalysis

[ APPLICATION NOTE ] The Separation of 8 -THC, 9 -THC, and Their Enantiomers by UPC 2 Using Trefoil Chiral Columns INTRODUCTION APPLICATION BENEFITS

Direct Analysis of Folic Acid in Digestive Juices by LC/TOF-MS Application

Research Article. Control of Transdermal Permeation of Hydrocortisone Acetate from Hydrophilic and Lipophilic Formulations

Residue Monograph prepared by the meeting of the Joint FAO/WHO Expert Committee on Food Additives (JECFA), 82 nd meeting 2016.

This brings me to my point. Disease starts when there is a surplus or deficiency of certain nutritive or non-nutritive substances in the human body.

International Journal of Pharma and Bio Sciences

Available online Research Article

Robust extraction, separation, and quantitation of structural isomer steroids from human plasma by SPE-UHPLC-MS/MS

Cannabinoid Profiling and Quantitation in Hemp Extracts using the Agilent 1290 Infinity II/6230B LC/TOF system

Analysis of bisphenol A leaching from baby feeding bottles

Transcription:

COSMETIC PATCHES CONTAINING SOY ISOFLAVONES Paola Minghetti, Antonella Casiraghi, Francesco Cilurzo, Luisa Montanari Istituto di Chimica Farmaceutica e Tossicologica, Università degli studi di Milano Introduction Phytoestrogens are plant-derived nonsteroidal compounds that possess estrogen-like biological activity. Among all classes of phytoestrogens that have been reported, lignans, coumenstans, and isoflavones appear of particular interest from a health perspective and in particular genistein (GEN) and daidzein (DAI). These naturally occurring isoflavones derived from soybeans have shown estrogenic activity. Epidemiological studies suggest that an elevated intake of DAI and GEN reduced the incidence of many hormone-dependent diseases. Researchers demonstrated that such isoflavones reduce the risk of breast and prostate cancer, as well as cardiovascular diseases, and improve bone health in an animal model. Moreover, they have been proposed as an alternative to conventional hormone replacement therapy for the treatment of postmenopausal diseases. As cosmetic use, phytoestrogens and in particular DAI and GEN are of interest as they can intensely moisturize and restructure the skin. The skin s surface regain density and skin features are visibly toned. Till today the main intake of soy derivatives is in dietary or as supplements. Transdermal application can be considered as an alternative route of administration of isoflavones, that allows to avoid the metabolic processes associated with the gastrointestinal system and liver. Moreover, by using patches, it could be obtained a prolonged release of GEN and DAI. The aim of this study was to evaluate the feasibility of the (trans)dermal administration of GEN and DAI contained in a commercial standardized soy dry extract by using monolayer methacrylic patches. The influence of the polymer type and enhancers on GEN and DAI skin permeation was evaluated. Preliminarily the effects induced by different skin permeation enhancers on GEN and DAI skin permeation were verified. The skin permeation study was performed by using modified Franz diffusion cell and the human stratum corneum and epidermis as a membrane. MATERIALS and METHODS Materials Genimax, soy dry extract, containing 40% w/w of total isoflavones, corresponding to 25% w/w of GEN and DAI (Sochim, I).

Transcutol, TR, and Labrasol, LB (Gattefossè, F). Propylene glycol, PG (Carlo Erba, I). Glycerol, GLY, and polyethylene glycol 400, PEG400 (ACEF, I). Oleic acid, OA (Polichimica, I). Eudragit E 100, EUE100, and Eudragit L 100-55, EUL100 (Röhm, G). Kollidon 90F, K90F, (BASF, G). Lauric acid, LA, (Fluka, G). Polyethylene was used as backing layer. Solubility studies The solubility of the extract in water and in different permeation enhancers was obtained by equilibrating for 24 hours large excesses of the solute and the vehicle at 32 C. The permeation enhancers were: OA, LB, TR, PEG400 and PG. Patch preparation The patches were prepared by using a laboratory coating unit Mathis LTE-S (M) (CH). The composition of the patches is reported in Table 1. Table 1: Composition of the patches containing soy dry extract (% w/w) Formulation Soy dry extract EUE100 EUL100 + KOH K90F GLY PEG400 PG LA 1 13.5-29.7 19.6 17.2-20.0-2 13.5-29.7 19.6 17.2 20.0 - - 3 13.5 30.3-31.1 - - 20.1 5.0 4 13.5 30.3-31.1-20,1-5.0 GEN and DAI content A 2,54 cm 2 sample of the patch was solubilized with methanol. The solutions were filtered and assayed by the HPLC method described below. Ex vivo permeation study The skin permeation tests were performed by using modified Franz diffusion cells and as a membrane human stratum corneum and epidermis. Sink conditions were maintained throughout the experiment. After 24 h solutions or the patch were removed and the epidermal surface of the skin was washed, then cut into small pieces and added to methanol. The suspension, soaked for 30 min, was stored for 12 h and then filtered. The GEN and DAI were assayed by the method described below.

Adhesion properties Peel adhesion 180 test. The force was expressed in centinewton (cn) per centimeter width of patch under test. Peel adhesion values were obtained from triplicate determinations. Probe tack test. The force was expressed in Newton (N). Tack values were obtained from five determinations. GEN and DAI assay The analytical instrument was an HPLC (HP 1100, Chemstations, Hewlett Packard, USA). Conditions of the isocratic method are injection volume at 10 µl, at a flow rate of 1 ml/min, and ultraviolet absorbance was monitored at 260 nm. Separation of the individual isoflavones was obtained on a C18 reverse-phase column (Hypersil, 5 µmspherisorb ODS2, 4.6 200 mm, Waters, UK). The mobile phase was methanol-2 mmol/l and ammonium acetate (55/45, v/v) and temperature was fixed at 25 C. A standard calibration curve (0.1 50 µg/ml) for each molecule was used. The detection limit was 0.03 µg/ml for DAI and 0.05 µg/ml for GEN. Resolution from the background noise was adequate at this level. The other substances of the soy extract did not interfere in DAI and GEN determination. The retention time of GEN and DAI was 10 min and 7 min, respectively. Conditions of the gradient method were injection volume at 10 µl, at a flow rate of 1 ml/min, and ultraviolet absorbance was monitored at 260 nm. Separation of the individual isoflavones was obtained on a C18 reverse-phase column (Hypersil). Temperature was fixed at 25 C. The mobile phase was 100% of 10 mmol/l ammonium acetate (0.1% trifluoroacetic acid) held isocratic for the first 2 min and then decreased to 50% at a constant gradient from 2 to 24 min, then finally held isocratic with 50% acetonitrile and 50% 10 mmol/l ammonium acetate (0.1% trifluoroacetic acid) for 5 min, before being returned to the original composition of 100% 10 mmol/l ammonium acetate (0.1% trifluoroacetic acid). The retention time of GEN and DAI was 25 min and 22 min, respectively. RESULTS and DISCUSSION Characterization of the extract The dry soy extract, analyzed by the gradient method, exclusively contained the aglycones GEN and DAI in the of 24% m/m, corresponding to 11.7% m/m GEN and 12.3% m/m DAI and indicating that the extraction method caused the hydrolysis of the conjugated forms of the isoflavones.

GEN and DAI solubility The solubilities of GEN and DAI contained in the dry extract in the selected vehicles are reported in Table 2. The solubility of both the isoflavones in water was the lowest and very close to that measured in OA (less than 0.1 mg/ml, Table 2). GEN was more soluble than DAI in PG and LB. Table 2 - Solubility of GEN and DAI contained in the dry soy extract (n=3, mean ± s.d.) Vehicle GEN (mg/ml) DAI (mg/ml) PEG400 8.51 ± 0.43 8.53 ± 0.46 LB 8.05 ± 0.21 5.73 ± 0.12 TR 6.83 ± 0.03 6.86 ± 0.03 PG 4.34 ± 0.03 2.61 ± 0.02 OA 0.025 ± 0.008 0.001 ± 0.001 Water 0.015 ± 0.005 0.013 ± 0.01 GEN and DAI content In all patches the average content of GEN was 107,507±3,422 µg/cm 2 ±d.s. and of DAI was 21,327±1,095 µg/cm 2 ±d.s. Ex vivo skin permeation of phytocomplex and patch PEG400 induced the highest fluxes. These flux values were not significantly different than those obtained by using PG solutions. The fluxes obtained by using the other enhancers were less than 0.04 µg/cm 2 /h (Table 3). Table 3 - Permeation parameters of GEN and DAI from the dry soy extract saturated vehicles (n=3, mean ± s.d.) GEN DAI Vehicle Permeated after 24h K p (cm 2 /h) Permeated after 24h K p (cm 2 /h) PEG400 31.7 ± 8.7 1.3 ± 0.4 1.5 x 10-4 23.9 ± 11.9 1.0 ± 0.5 1.2 x 10-4 LB 5.6 ± 0.4 -** - -* - - TR 5.8 ± 0.2 -** - -* - - PG 12.3 ± 3.2 0.5 ± 0.1 1.2 x 10-5 9.8 ± 3.9 0.4 ± 0.2 1.5 x 10-5 OA -* - - -* - - Water -* - - -* - - Note: *not detectable; **lower than 0.1 µg/cm 2 /h. Considering the lipophilic characteristic of these molecules (logp GEN: 3,72; logp DAI: 4,72) they could be retained in the skin in a significant. Therefore, in the case of PEG, the permeation enhancer showing the highest permeated of both isoflavones, the retained into the stratum corneum and epidermis was measured: GEN 38.9 mg/cm 2 and DAI 2.8 mg/cm 2.

PEG400 and PG were therefore used as enhancers in the patches. For each patch the permeated s of GEN were higher than those of DAI. In the case of GEN, the patches based on EUL100 showed higher permeated and retained than those obtained by using EUE100 (Table 4). No differences in term of skin permeation seemed to be due to the type of enhancer (Table 4). Table 4 - Permeation parameters of GEN and DAI from patches (n=3, mean ± s.d.) GEN DAI Formulation Permeated after 72h Retained Permeated after 72h Retained 1 2,0±0,1 0,026±0,017 17,4±5,8 0,4±0,3 0,004±0,003 2,1±2,1 2 1,7±0,7 0,021±0,001 11,9±6,7 0,6±0,2 0,005±0,004 6,3±4,0 3 0,4±0,7 0,002±0,001 5,6±4,3 0,6±0,3 0,005±0,002 0,6±0,2 4 0,5±0,0 0,005±0,001 6,5±5,7 0,6±0,3 0,006±0,005 3,1±3,1 Adhesion properties The peel adhesion values of patches based on EUL100 were higher than those of patches based on EUE100. Formulations containing PEG400 showed peel adhesion and tack values slightly higher than those of formulations containing PG (Table 5). The CV of each sample in the peel adhesion assay was less than 10% indicating a good matrix cohesion. Table 5 - Peel adhesion and tack values of patches Formulation Peel adhesion Probe Tack Test (cn/cm; n=3, mean±d.s.) Max detachment load (N; n=5, mean±d.s.) Detachment work (mj; n=5, mean±d.s.) 1 137±3 0,23±0,08 0,094±0,036 2 151±55 0,27±0,06 0,097±0,013 3 82±5 1,04±0,31 0,538±0,165 4 93±1 1,23±0,09 0,656±0,034 CONCLUSIONS Monolayer transdermal patches containing soy extract with good technological characteristics were prepared with matrices made of methacrylic copolymers. Best performances in terms of retained into skin were obtained by using EUL100 as polymeric system. PEG400 and PG, the selected enhancers, seems to not have a different enhancement effect.